Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Didier Boturyn

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
EJNMMI Research|June 21, 2018
Uniform intratumoral distribution of radioactivity produced using two different radioagents, <sup>64</sup>Cu-cyclam-RAFT-c(-RGDfK-)<sub>4</sub> and <sup>64</sup>Cu-ATSM, improves therapeutic efficacy in a small animal tumor modelZhao-Hui Jin, Atsushi B Tsuji, Mélissa Degardin, et al.
Molecular Imaging|August 29, 2013
Micro-positron emission tomography/contrast-enhanced computed tomography imaging of orthotopic pancreatic tumor-bearing mice using the αvβ₃ integrin tracer ⁶⁴Cu-labeled cyclam-RAFT-c(-RGDfK-)₄Winn Aung, Zhao-Hui Jin, Takako Furukawa, et al.
Molecular Cancer Therapeutics|July 17, 2016
αVβ3 Integrin-Targeted Radionuclide Therapy with 64Cu-cyclam-RAFT-c(-RGDfK-)4Zhao-Hui Jin, Takako Furukawa, Mélissa Degardin, et al.
Nuclear Medicine Communications|March 15, 2017
67Cu-Radiolabeling of a multimeric RGD peptide for αVβ3 integrin-targeted radionuclide therapy: stability, therapeutic efficacy, and safety studies in miceZhao-Hui Jin, Takako Furukawa, Tomoyuki Ohya, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 10, 2013
PET imaging and biodistribution analysis of the effects of succinylated gelatin combined with L-lysine on renal uptake and retention of ⁶⁴Cu-cyclam-RAFT-c(-RGDfK-)₄ in vivoZhao-Hui Jin, Takako Furukawa, Chizuru Sogawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2020
Radiotheranostic Agent <sup>64</sup>Cu-cyclam-RAFT-c(-RGDfK-)<sub>4</sub> for Management of Peritoneal Metastasis in Ovarian CancerZhao-Hui Jin, Atsushi B Tsuji, Mélissa Degardin, et al.
Journal of Materials Chemistry. B|April 9, 2020
Correction: Multivalency: influence of the residence time and the retraction rate on rupture forces measured by AFMJalal Bacharouche, Mélissa Degardin, Loïc Jierry, et al.
Beilstein Journal of Organic Chemistry|August 17, 2018
Synthesis and photophysical studies of a multivalent photoreactive Ru<sup>II</sup>-calix[4]arene complex bearing RGD-containing cyclopentapeptidesSofia Kajouj, Lionel Marcelis, Alice Mattiuzzi, et al.
Cancer Science|March 28, 2012
Reduction of renal uptake of 111In-DOTA-labeled and A700-labeled RAFT-RGD during integrin αvβ3 targeting using single photon emission computed tomography and optical imagingArnaud Briat, Christiane H F Wenk, Mitra Ahmadi, et al.
Journal of Materials Chemistry. B|April 9, 2020
Multivalency: influence of the residence time and the retraction rate on rupture forces measured by AFMJalal Bacharouche, Mélissa Degardin, Loïc Jierry, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
EJNMMI Research|June 21, 2018
Uniform intratumoral distribution of radioactivity produced using two different radioagents, <sup>64</sup>Cu-cyclam-RAFT-c(-RGDfK-)<sub>4</sub> and <sup>64</sup>Cu-ATSM, improves therapeutic efficacy in a small animal tumor modelZhao-Hui Jin, Atsushi B Tsuji, Mélissa Degardin, et al.
Molecular Imaging|August 29, 2013
Micro-positron emission tomography/contrast-enhanced computed tomography imaging of orthotopic pancreatic tumor-bearing mice using the αvβ₃ integrin tracer ⁶⁴Cu-labeled cyclam-RAFT-c(-RGDfK-)₄Winn Aung, Zhao-Hui Jin, Takako Furukawa, et al.
Molecular Cancer Therapeutics|July 17, 2016
αVβ3 Integrin-Targeted Radionuclide Therapy with 64Cu-cyclam-RAFT-c(-RGDfK-)4Zhao-Hui Jin, Takako Furukawa, Mélissa Degardin, et al.
Nuclear Medicine Communications|March 15, 2017
67Cu-Radiolabeling of a multimeric RGD peptide for αVβ3 integrin-targeted radionuclide therapy: stability, therapeutic efficacy, and safety studies in miceZhao-Hui Jin, Takako Furukawa, Tomoyuki Ohya, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 10, 2013
PET imaging and biodistribution analysis of the effects of succinylated gelatin combined with L-lysine on renal uptake and retention of ⁶⁴Cu-cyclam-RAFT-c(-RGDfK-)₄ in vivoZhao-Hui Jin, Takako Furukawa, Chizuru Sogawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2020
Radiotheranostic Agent <sup>64</sup>Cu-cyclam-RAFT-c(-RGDfK-)<sub>4</sub> for Management of Peritoneal Metastasis in Ovarian CancerZhao-Hui Jin, Atsushi B Tsuji, Mélissa Degardin, et al.
Journal of Materials Chemistry. B|April 9, 2020
Correction: Multivalency: influence of the residence time and the retraction rate on rupture forces measured by AFMJalal Bacharouche, Mélissa Degardin, Loïc Jierry, et al.
Beilstein Journal of Organic Chemistry|August 17, 2018
Synthesis and photophysical studies of a multivalent photoreactive Ru<sup>II</sup>-calix[4]arene complex bearing RGD-containing cyclopentapeptidesSofia Kajouj, Lionel Marcelis, Alice Mattiuzzi, et al.
Cancer Science|March 28, 2012
Reduction of renal uptake of 111In-DOTA-labeled and A700-labeled RAFT-RGD during integrin αvβ3 targeting using single photon emission computed tomography and optical imagingArnaud Briat, Christiane H F Wenk, Mitra Ahmadi, et al.
Journal of Materials Chemistry. B|April 9, 2020
Multivalency: influence of the residence time and the retraction rate on rupture forces measured by AFMJalal Bacharouche, Mélissa Degardin, Loïc Jierry, et al.
Pageof 9